Varaico: Literature-Extracted Genetic Variants

Gene:G6PC1
Variant:p.Q347*
Back to variants list

G6PC1

NM_000151.4:p.Q347*

Associated Papers

Clinical, laboratory and molecular features of glycogen storage disease type 1a and 1b patients from Turkey: novel mutations and phenotypes.

Akyüz A et al.

European Journal of Pediatrics, 2025

Clinical characteristics of 50 hepatocellular adenoma patients among 164 cases of glycogen storage disease type Ia.

Xu Y et al.

European Journal of Pediatrics, 2025

Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa).

Weinstein DA et al.

Journal of Inherited Metabolic Disease, 2025

Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management.

Vela-Amieva M et al.

International Journal of Molecular Sciences, 2024

A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.

Wang A et al.

Bmc Medical Genomics, 2024

Blood glucose trends in glycogen storage disease type Ia: A cross-sectional study.

Fukuda T et al.

Journal of Inherited Metabolic Disease, 2023

Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.

Bonfiglio F et al.

Ebiomedicine, 2023

36493725 (PubMed )
Supplement: mmc1.xlsx › Table_S8

Gene therapy and genome editing for type I glycogen storage diseases.

Chou JY et al.

Frontiers in Molecular Medicine, 2023

Large-scale exome array summary statistics resources for glycemic traits to aid effector gene prioritization.

Willems SM et al.

Wellcome Open Research, 2023

Glycogen storage disease type 1a in the Ohio Amish.

Scott EM et al.

Jimd Reports, 2022

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia.

Haring MPD et al.

Jhep Reports : Innovation in Hepatology, 2022

Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature.

Xu N et al.

Arthritis Research & Therapy, 2022

DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis.

Niba ETE et al.

International Journal of Neonatal Screening, 2021

Classifying molecular phenotypes of G6PC variants for pathogenic properties and to guide therapeutic development.

Plona KL et al.

Jimd Reports, 2021

Neurological Characteristics of Pediatric Glycogen Storage Disease.

Muzetti JH et al.

Frontiers in Endocrinology, 2021

The rs2229611 (G6PC:c.*23 T>C) is associated with glycogen storage disease type Ia in Brazilian patients.

Pinheiro FC et al.

Molecular Genetics and Metabolism Reports, 2020

Novel variants in Turkish patients with glycogen storage disease.

Çakar NE et al.

Pediatrics International : Official Journal of the Japan Pediatric Society, 2020

Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.

Perry A et al.

Jimd Reports, 2020

Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.

Kim YM et al.

Orphanet Journal of Rare Diseases, 2020

Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients.

Sperb-Ludwig F et al.

Molecular Genetics & Genomic Medicine, 2019

Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes.

Capalbo A et al.

Plos Genetics, 2019

Molecular diagnosis of glycogen storage disease type I: a review.

Beyzaei Z et al.

Excli Journal, 2019

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas.

Moest W et al.

Hepatology (baltimore, Md.), 2018

Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants.

Skakic A et al.

Clinical Genetics, 2018

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.

Peeks F et al.

Journal of Inherited Metabolic Disease, 2017

Recent development and gene therapy for glycogen storage disease type Ia.

Chou JY et al.

Liver Research (beijing, China), 2017

Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review.

Zhang B et al.

Clinical Rheumatology, 2016

Progressive development of renal cysts in glycogen storage disease type I.

Gjorgjieva M et al.

Human Molecular Genetics, 2016

Human Metabolic Enzymes Deficiency: A Genetic Mutation Based Approach.

Chaturvedi S et al.

Scientifica, 2016

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia.

Zheng BX et al.

European Journal of Pediatrics, 2015

De novo mutations in moderate or severe intellectual disability.

Hamdan FF et al.

Plos Genetics, 2014

25356899 (PubMed )
Supplement: pgen.1004772.s004.xlsx › 1861.653

Determining mutations in G6PC and SLC37A4 genes in a sample of Brazilian patients with glycogen storage disease types Ia and Ib.

Carlin MP et al.

Genetics and Molecular Biology, 2013

Rapid screening of 12 common mutations in Turkish GSD 1a patients using electronic DNA microarray.

Eminoglu TF et al.

Gene, 2013

Glucose-6-phosphatase deficiency.

Froissart R et al.

Orphanet Journal of Rare Diseases, 2011

Preemptive liver-kidney transplantation in von Gierke disease: a case report.

Marega A et al.

Transplantation Proceedings, 2011

Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Chou JY et al.

Nature Reviews. Endocrinology, 2010

Emerging therapies for glycogen storage disease type I.

Koeberl DD et al.

Trends in Endocrinology and Metabolism: Tem, 2009

Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Chou JY et al.

Human Mutation, 2008

Glycogen storage diseases: new perspectives.

Ozen H

World Journal of Gastroenterology, 2007

Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.

Belingheri M et al.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007

Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.

Shin YS

Seminars in Pediatric Neurology, 2006

Inherited hyperuricemic disorders.

Nyhan WL

Contributions to Nephrology, 2005

Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population.

Ekstein J et al.

American Journal of Medical Genetics. Part A, 2004

Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.

Matern D et al.

European Journal of Pediatrics, 2002

The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase.

Shieh JJ et al.

The Journal of Biological Chemistry, 2002

1–50 of 74 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."